Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 607 across all filing types
Latest filing 2020-10-01 Major Shareholding Noti…
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with 'RNS Number : 8809A' and contains the standard header/footer information associated with RNS (Regulatory News Service) releases from the London Stock Exchange. The content itself is a 'TR-1: Standard form for notification of major holdings,' which details changes in share ownership thresholds by a significant shareholder (BGF Investment Management Limited). This type of filing, reporting changes in significant shareholdings, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2020-10-01 English
South African approval
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 5096A' and contains language typical of regulatory news services, such as 'The information contained within this Announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this Announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.' It announces a specific event (approval of a kit in South Africa) and concludes with boilerplate text referencing RNS and the London Stock Exchange. This structure strongly indicates a general regulatory announcement that doesn't fit the more specific categories like 10-K, ER, or DIV. Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for such announcements.
2020-09-30 English
Partial Conversion of Loan Notes
Capital/Financing Update Classification · 1% confidence The document starts with an 'RNS Number' and is dated September 28, 2020. The content describes a specific corporate action: the partial conversion of Loan Notes into new ordinary shares by an investor (BGF Investments LP), resulting in a change to the total number of shares in issue. This is a material event announcement typically disseminated via regulatory news services. Since it involves a change in capital structure (new shares issued) but is framed as a specific transaction/event notification rather than a general capital raising announcement (CAP) or a formal share repurchase (POS), and it is clearly distributed via RNS (London Stock Exchange's news service), it fits best under the general 'Regulatory Filings' category (RNS) as a specific corporate event disclosure, or potentially 'CAP' or 'SHA'. However, given the explicit RNS header and the nature of the announcement (conversion of debt into equity, affecting share count), RNS is the most appropriate general regulatory disclosure bucket if a more specific code like SHA (Share Issue/Capital Change) isn't strictly required for debt conversion. Since the core event is a change in the number of shares outstanding following a financing instrument conversion, SHA is highly relevant. However, the document is explicitly branded as an RNS release, which is the fallback for general regulatory announcements. Given the options, this is a specific corporate action announcement distributed via RNS. It is not a full report, nor is it a dividend or management change. It is a notification of a change in share capital resulting from a debt conversion. I will classify it as RNS as it is the distribution mechanism and a general regulatory filing, but note that SHA is closely related. Given the explicit RNS branding and the nature of the announcement (not a primary offering or buyback, but a conversion), RNS is the safest classification for a general regulatory disclosure.
2020-09-28 English
Verification with Beckman Coulter Life Sciences
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated September 25, 2020. It contains a headline announcing a technical milestone regarding the Genedrive SARS-CoV-2 Kit verification with Beckman Coulter chemistry. The text is a brief operational update concerning product development and validation, concluding with contact details and a disclaimer referencing RNS and the London Stock Exchange. This format is characteristic of a general regulatory announcement or news release disseminated via the London Stock Exchange's RNS service, rather than a comprehensive financial report (like 10-K or IR) or a specific corporate action notice (like DIV or DIRS). Since it is a general regulatory announcement that doesn't fit the more specific categories, the fallback 'Regulatory Filings' (RNS) is the most appropriate classification.
2020-09-25 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains fields detailing changes in voting rights percentages, shareholder names, and dates of crossing thresholds. This structure is characteristic of regulatory filings related to significant ownership changes. The presence of 'RNS Number' and the footer mentioning the 'London Stock Exchange' and 'Financial Conduct Authority' confirms it is a regulatory disclosure. The specific nature of reporting major holdings aligns directly with the definition of a Major Shareholding Notification (MRQ).
2020-09-21 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1900 characters) and contains the header 'RNS Number : 4761Z' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific, immediate operational announcement. This type of brief, time-sensitive regulatory update that doesn't fit into the major financial reporting categories (like 10-K, ER, IR) is best classified as a general Regulatory Filing (RNS), as it is distributed via the RNS system.
2020-09-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.